Loading…

Neurocognitive performance after PCSK9 inhibitor therapy: Current state of the evidence

Saved in:

Bibliographic Details
Published in:	Journal of neuroscience research 2018-05, Vol.96 (5), p.762-764
Main Authors:	Stamerra, Cosimo Andrea, Di Giosia, Paolo, Giorgini, Paolo, De Feo, Martina, Grassi, Davide, Ferri, Claudio, Sahebkar, Amirhossein
Format:	Article
Language:	English
Subjects:	Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Anticholesteremic Agents - administration & dosage Anticholesteremic Agents - adverse effects Atherosclerosis Cognition Cognition Disorders - chemically induced Cognition Disorders - metabolism Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects Hypercholesterolemia - drug therapy Hypercholesterolemia - metabolism Hypercholesterolemia - psychology lipids neurocognitive events PCSK9 inhibitors Proprotein Convertase 9 - antagonists & inhibitors Randomized Controlled Trials as Topic statins
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!